kei miyakawa
National Institute of Infectious Diseases (NIID)
Tokyo, Japan
Review Editor
Antivirals and Vaccines
Editors
National Institute of Infectious Diseases (NIID)
Tokyo, Japan
Review Editor
Antivirals and Vaccines
Michigan Medicine, University of Michigan
Ann Arbor, United States
Review Editor
Antivirals and Vaccines
Joint Research Center for Human Retrovirus Infection, Kumamoto University
Kumamoto, Japan
Review Editor
Antivirals and Vaccines
Chumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products (RAS)
Moscow, Russia
Review Editor
Antivirals and Vaccines
Centers for Disease Control and Prevention (CDC)
Atlanta, United States
Review Editor
Antivirals and Vaccines
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Antivirals and Vaccines
Fred Hutchinson Cancer Center
Seattle, United States
Review Editor
Antivirals and Vaccines
Independent researcher
CSL Seqirus, United States
Review Editor
Antivirals and Vaccines
Rega Institute for Medical Research, Faculty of Medicine, KU Leuven
Leuven, Belgium
Review Editor
Antivirals and Vaccines
Vir Biotechnology, Inc.
San Francisco, United States
Review Editor
Antivirals and Vaccines
University of Illinois Chicago
Chicago, United States
Review Editor
Antivirals and Vaccines
KU Leuven
Leuven, Belgium
Review Editor
Antivirals and Vaccines
University of Arizona
Tucson, United States
Review Editor
Antivirals and Vaccines
Chungnam National University
Daejeon, Republic of Korea
Review Editor
Antivirals and Vaccines
University of New Mexico
Albuquerque, United States
Review Editor
Antivirals and Vaccines
Andusian Health Service
Seville, Spain
Review Editor
Antivirals and Vaccines